全文获取类型
收费全文 | 16065篇 |
免费 | 1022篇 |
国内免费 | 331篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 448篇 |
妇产科学 | 147篇 |
基础医学 | 2453篇 |
口腔科学 | 115篇 |
临床医学 | 812篇 |
内科学 | 2362篇 |
皮肤病学 | 132篇 |
神经病学 | 125篇 |
特种医学 | 107篇 |
外国民族医学 | 1篇 |
外科学 | 387篇 |
综合类 | 1299篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 6930篇 |
眼科学 | 69篇 |
药学 | 1127篇 |
4篇 | |
中国医学 | 68篇 |
肿瘤学 | 793篇 |
出版年
2024年 | 21篇 |
2023年 | 550篇 |
2022年 | 996篇 |
2021年 | 893篇 |
2020年 | 714篇 |
2019年 | 629篇 |
2018年 | 682篇 |
2017年 | 593篇 |
2016年 | 603篇 |
2015年 | 695篇 |
2014年 | 806篇 |
2013年 | 1199篇 |
2012年 | 871篇 |
2011年 | 1002篇 |
2010年 | 827篇 |
2009年 | 797篇 |
2008年 | 503篇 |
2007年 | 664篇 |
2006年 | 570篇 |
2005年 | 507篇 |
2004年 | 474篇 |
2003年 | 426篇 |
2002年 | 343篇 |
2001年 | 310篇 |
2000年 | 262篇 |
1999年 | 249篇 |
1998年 | 167篇 |
1997年 | 166篇 |
1996年 | 116篇 |
1995年 | 88篇 |
1994年 | 77篇 |
1993年 | 77篇 |
1992年 | 55篇 |
1991年 | 54篇 |
1990年 | 54篇 |
1989年 | 62篇 |
1988年 | 50篇 |
1987年 | 36篇 |
1986年 | 37篇 |
1985年 | 63篇 |
1984年 | 35篇 |
1983年 | 20篇 |
1982年 | 20篇 |
1981年 | 16篇 |
1980年 | 10篇 |
1979年 | 7篇 |
1978年 | 8篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1974年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
111.
目的:探讨马传染性贫血病毒驴白细胞减毒疫苗免疫马后,外周血单个核细胞中Th1型细胞因子转录水平与免疫保护应答的关系,揭示DLV的免疫保护机制。方法:应用分子克隆及实时定量RT-PCR技术,建立了马PBMC中IFNγ-、IL-2、IL-12 mRNA转录水平的定量检测方法,定期观察4组(疫苗免疫组、阴性对照组、强毒株阳性对照组、自然感染组)12匹马外周血PBMC中细胞因子的转录水平及分布特征,同时监测体温变化等指标。疫苗株免疫动物8个月后,用EIAV强毒株攻击,观察攻击前后细胞因子转录水平的变化。结果:DLV免疫马,在免疫后3周外周血PBMC中IFN-γ、IL-2转录量显著高于阴性对照组及自然感染组(P〈0.01);免疫后用EIAV强毒株攻击,IFNγ-、IL-2和IL-12转录的量明显升高,免疫马获得完全保护;强毒株攻击阳性对照马IFN-γ、IL-2转录量随疾病进展波动,发热期下降。结论:本研究首次证明EIAV减毒疫苗可诱导马外周血PBMC中IFN-γ、IL-2、IL-12基因高效转录,其转录水平与DLV的免疫保护密切相关,此结果在分子水平为阐明DLV的免疫保护机制提供了新的实验依据。 相似文献
112.
Horizontal transmission of hepatitis B virus infection in household contacts, Pune, India 总被引:1,自引:0,他引:1
The study was undertaken to detect the risk of infection, if any, among 193 household contacts of 40 hospitalised hepatitis patients (group I) with hepatitis B surface antigen (HBsAg) in their blood. As a control group, 103 household contacts of 27 hospitalised hepatitis patients who were negative for HBsAg (group II) were investigated. The family contacts of the former group had a significantly higher prevalence of HBV infection than those of the latter group (P less than .001). Significant differences were observed both in the prevalence of HBsAg (P less than .05) and antibody to HBsAg (anti-HBs) (P less than .025) between the two groups. IgM antibody to hepatitis B core antigen (anti-Hbc-IgM) was detected in 32 out of the 39 (82%) sera tested from the patients of group I with HBsAg. A statistically significant difference (P less than .005) of HBV prevalence was also found in the contacts of these 32 patients suffering from acute hepatitis B as compared to the contacts of the patients of group II. Overall, the children of the first group showed a significantly higher prevalence of HBsAg as compared to the second group. All the children with HBsAg were positive for HBeAg also, but were negative for anti-HBc-IgM. Anti-HBs was detected in a significantly larger number of adult females. Spouses were found to be affected more than other relatives. A significant difference (P less than .025) was noted in the number of families having HBV markers in group I (80.0%) as compared to those in group II (48.1%).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
113.
树突状细胞负载肝癌抗原肽疫苗体外诱导特异性免疫学反应的研究 总被引:1,自引:1,他引:1
目的:研究树突状细胞(dendritic cell,DC)负载肝癌抗原肽EPVTKAEML体外诱导特异性CTL的能力及其抑癌效果。方法:用顺序特异引物聚合酶链反应技术(PCR—SSP)选择HLA—B7表型供者,从脾组织中分离、培养DC-EPVTKAEML特异性CTL。用^51Cr释放法检测CTL的杀伤活性,并用抗HLA-1分子单抗(mAb)进行杀伤抑制实验。结果:找到4例HLA-B7杂合子供者,用DC负载HLA-B7限制的抗原肽EPVTKAEML可诱导特异性CTL反应,对肝癌细胞HHCC有较强的杀伤作用。结论:DC负载抗原肽EPVTKAEML在体外可诱发较强的特异性免疫反应。 相似文献
114.
目的:构建、制备单纯疱疹病毒Ⅰ型(HSV-Ⅰ)糖蛋白BDNA疫苗,检测其诱导机体产生的细胞免疫应答。方法:PCR扩增编码HSV-Ⅰ gB去除N端部分信号肽序列(39bp)的基因片段(2673bp),定向插入pcDNA3载体中,构建pcDNA3-gB基因疫苗并对其进行PCR、酶切及测序鉴定。于BALB/c小鼠注射免疫3次,观察小鼠CD4^ 、CD8^ T细胞亚群的变化,CFSE/PI双标记的流式细胞计数法检测CTL活性。结果:双酶切分析结果为目的基因(2.7kb)和线性质粒pcDNA3(5.4kb);PCR扩增结果为特异产物(2.7kb);测序结果与GenBank gB基因序列同源性达99.5%;CTL,活性增强;BALB/c小鼠脾CD4^ T细胞增加。结论:经鉴定证实了HSV-Ⅰ gB基因疫苗的构建;HSV-Ⅰ gB基因疫苗可以诱导较强的细胞免疫应答,应用于预防HSV-Ⅰ的感染具有良好的前景。 相似文献
115.
Response to a hepatitis B polypeptide vaccine in micelle form in a young adult population 总被引:2,自引:0,他引:2
F B Hollinger C Troisi D Heiberg Y Sanchez G R Dreesman J L Melnick 《Journal of medical virology》1986,19(3):229-240
Polypeptide micelles with relative molecular weights of 25,000 (p25) and 30,000 (gp30) daltons were prepared from native 22-nm hepatitis B surface antigen (HBsAg) particles. This p25/gp30 complex was alum-adsorbed, and three dosage levels (20 micrograms, 4 micrograms, and 0.8 micrograms) were administered at 0, 1, and 6 months to 51 human volunteers. Local and systemic reactions were clinically insignificant, and all vaccinees seroconverted, regardless of dose. As anticipated, antibody responses diminished as the dosage was reduced. Seroconversion rates and geometric mean antibody levels for the 20 micrograms dosage group were significantly better than those observed with a commercial vaccine and were comparable to those achieved after immunization with 40 micrograms of the intact 22-nm particles used to prepare the polypeptides. By 2 weeks, an anti-HBs response was elicited in 80% of the group receiving 20 micrograms of the polypeptide vaccine. This rapid response to immunization may be particularly beneficial for postexposure prophylaxis where the early development of immunity is advantageous. 相似文献
116.
117.
Effects of Killed and Live Attenuated Influenza Vaccine on Symptoms and Specific Airway Conductance in Asthmatics and Healthy Subjects 总被引:1,自引:0,他引:1
Killed and live influenza virus vaccines were given to asthmatics and healthy subjects to investigate symptoms and alterations in their respiratory performance after vaccination. Polyvalent killed influenza virus vaccine was given to 16 asthmatics and live attenuated influenza virus vaccine to 23 asthmatics and 21 healthy subjects. Fourteen of the 16 asthmatics vaccinated with the killed vaccine displayed a significant rise in serum antibody level as measured by a single radial haemolysis in gel (SRH test). 11 of the 23 asthmatics and 14 of the 21 healthy subjects vaccinated with the live attenuated vaccine displayed a significant rise in the SRH test. Among the subjects with no measurable initial antibodies and with a significant rise in the SRH test, one asthmatic vaccinated with the killed vaccine experienced symptoms of common cold with fever and dyspnoea 1 week after vaccination. Three asthmatics and four healthy subjects vaccinated with live attenuated vaccine experienced mild symptoms, mainly rhinorrhoea, cough and sore throat 2 to 3 days after vaccination. No alterations in specific airway conductance in asthmatics or in healthy subjects were observed. We conclude that both killed and live attenuated influenza virus vaccines are tolerated well by asthmatics and appear to be safe for asthma patients. 相似文献
118.
GM-CSF对MUC1基因疫苗抑制乳腺癌生长的增强作用 总被引:5,自引:2,他引:5
目的 :观察GM CSF有无增强MUC1基因疫苗对EMT6乳腺癌生长的特异性抑制作用。方法 :采用股四头肌肌肉注射法 ,将构建的MUC1基因疫苗pcDNA3.1 MUC1免疫雌性BALB/c小鼠 ,每 3wk 1次 ,共 3次。每次基因免疫后 1、3、5d ,皮下注射GM CSF 10 0 μL(1μg/ 10 0 μL)。最后 1次基因免疫后第 3周 ,接种表达MUC1的EMT6小鼠乳腺癌细胞。两周后观察、记录肿瘤的生长情况。于肿瘤细胞接种后第 4 3天 ,处死全部动物 ,称量肿瘤的质量。用 4h51Cr释放法检测小鼠脾特异性CTL的杀伤活性。结果 :接种肿瘤细胞后 4 3d ,MUC1基因疫苗加GM CSF组、MUC1基因疫苗组、pcDNA3.1加GM CSF组及pcDNA3.1组 ,EMT6肿瘤的大小依次为 (135± 33.8)mm3 、(2 5 0± 34.3)mm3 、(5 6 8± 4 3.6 )mm3 和 (5 96± 4 8.2 )mm3 ;平均瘤质量 (g)依次为 (0 .81± 0 .4 2 )g、(1.2 3± 0 .4 1)g、(2 .30± 0 .4 8)g及 (2 .2 8± 0 .5 8)g。与对照组相比较 ,MUC1基因疫苗组EMT6肿瘤的生长受到明显抑制 (P <0 .0 5 ) ;与单独MUC1基因疫苗组相比较 ,MUC1基因疫苗加GM CSF组抗肿瘤生长的作用有显著差异 (P <0 .0 5 )。在效靶比为 10 0∶1、5 0∶1、2 5∶1和 12 .5∶1时 ,MUC1基因疫苗加GM CSF组特异性CTL对EMT6靶细胞的杀伤率 ,依次为 6 8.5 %、 5 3.4 % 相似文献
119.
A rapid passive hemagglutination assay (Rubaquick) was developed that detects antibody to rubella virus in serum specimens. The test result is read visually after an incubation period of 15-30 minutes. When compared with a hemagglutination inhibition assay, the Rubaquick assay results obtained from 1,470 sera were greater than 99% specific, sensitive, and accurate. Studies of 179 paired serum specimens obtained before and 27 days after rubella vaccination showed that if antibody was detectable by the Rubaquick assay in the prevaccination specimens, the vaccine induced a secondary response consisting of increasing IgG antibody reactivity in the absence of a positive IgM response. In contrast to the positive prevaccination specimens, a negative prevaccination result was associated with IgM antibody in 98 of the 133 postvaccination specimens. Seroconversion was noted in all cases in which the prevaccination specimen was negative by the Rubaquick assay. 相似文献
120.
Amara RR Ibegbu C Villinger F Montefiori DC Sharma S Nigam P Xu Y McClure HM Robinson HL 《Virology》2005,343(2):246-255
Here, we study immune responses in four DNA/MVA-vaccinated macaques following an SHIV-89.6P challenge and a subsequent CD8 cell depletion. Both post-challenge and post-depletion peaks of viremia contracted with the expansion, or re-emergence, of CD8 T cells. Post-depletion, CD8 cells expanded in the presence of higher levels of neutralizing Ab and CD4 help than post-challenge and had superior maturational characteristics as measured by expression of the anti-apoptotic protein Bcl-2, the IL-7 receptor CD127 and co-production of IFN-gamma and IL-2. Pre-challenge and pre-depletion titers of neutralizing Ab correlated inversely with peaks of viremia and directly with peaks for anti-viral CD4 cells. Thus, our results reveal CD8 cells playing a central role, and neutralizing Ab, a supporting role in SHIV-89.6P control. They also suggest a dynamic relationship between neutralizing Ab, antigen load and anti-viral CD4 cells in the maturation of high-quality anti-viral CD8 T cells. 相似文献